DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International (BAX), will host a quarterly conference call to discuss its third quarter 2012 financial results on Thursday, October 18, 2012, at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). To access the call, please dial 866-818-1223 (domestic) or 703-639-1376 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you.

This call is being webcast by Thomson Reuters and can be accessed at Baxters Web site at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxters permission.

Baxter International, Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Baxter International Inc.
Investor Relations Contacts:
Mary Kay Ladone, +1.224.948.3371
Mary_Kay_Ladone@baxter.com
or
Clare Trachtman, +1.224.948.3085
Clare_Trachtman@baxter.com
or
Media Contacts
Deborah Spak, (224) 948-2349

Source: Baxter International Inc.